Read more at MarketWatch.
Viking Therapeutics’ stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD
Date: |
-
Business - MarketWatch
Scholar Rock’s stock soars more than 315% on positive trial of treatment for spinal muscular atrophy
The Phase 3 trial of apitegromab showed statistically significant improvement in motor function.Yesterday -
Business - MarketWatch
Biogen’s stock bounces after FDA boost on kidney-transplant rejection treatment
Biogen stock was headed higher Wednesday, to bounce off an 11-year closing low, after the biotechnology company received positive news from regulators about its treatment for kidney-transplant ...1 hour ago -
Business - MarketWatch
Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatment
Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease failed to ...Yesterday -
Business - MarketWatch
Lucid’s stock climbs, boosted by jump in vehicle deliveries
Lucid’s third-quarter vehicle deliveries are up 90% year-over-year.2 days ago -
Top stories - NBC News
Posts encouraging eating disorders were recommended to X users
Communities that promote eating disorders have been thriving on X, with some users saying the platform has recommended content to them that glorifies starving.Yesterday -
Business - The New York Times
China Stocks Surge After Government Measures to Boost Economy
The government has fired up investors by encouraging banks to lend more to buyers of stocks and real estate, but officials refrained on Tuesday from promising more stimulus.19 hours ago - China -
Top stories - NBC News
Florida prepares for Hurricane Milton and X exposes users to eating disorder content: Morning Rundown
Hurricane Milton could be the worst storm the Tampa region has seen in a century.Yesterday - Florida
More from MarketWatch
-
Business - MarketWatch
Why a CPI surprise could trip up the Fed’s rate-cutting plans
Employment and economic data already are surprising to the upside since the Federal Reserve cut rates in September1 hour ago -
Business - MarketWatch
Rio Tinto strikes $6.7 billion deal to buy Arcadium Lithium
Rio Tinto on Wednesday struck a deal to acquire Arcadium Lithium for $6.7 billion, as the global miner extends its operations in another commodity needed for the energy transition.1 hour ago -
Business - MarketWatch
Inflation still slowing, CPI to show, but some warning signs might flash
The rate of U.S. inflation is likely to slow again in September, but fresh doubts have emerged about whether the Federal Reserve can hit its 2% target earlier than expected.1 hour ago -
Business - MarketWatch
U.S., and intriguingly, Australia, have the most expensive stocks by one measure
Why one trader says most U.S. stocks are expensive, and many foreign ones are cheap.1 hour ago -
Business - MarketWatch
Biogen’s stock bounces after FDA boost on kidney-transplant rejection treatment
Biogen stock was headed higher Wednesday, to bounce off an 11-year closing low, after the biotechnology company received positive news from regulators about its treatment for kidney-transplant ...1 hour ago